Genetic Technologies Limited Gains 45.09%
Thu, Jan 09, 2020 at 05:30 PM
Genetic Technologies Limited (GENE:NASDAQ) rocketted at $4.73, representing a gain of 45.1%. The stock got featured on our News Catalysts scanner on Tue 07 Jan 20 at 01:16 PM in the 'BIOTECH' category. From Tue 17 Dec 19, the stock recorded 35.71% Up Days and 46.67% Green Days
The stock spiked on Tue 07 Jan 20 at $5.22 with a volume of 16M+.
About Genetic Technologies Limited (GENE:NASDAQ)
Genetic Technologies Ltd is a molecular diagnostics company. It offers predictive testing and assessment tools to help physicians manage women's health.
Top 10 Gainers:
- Applied Genetic Technologies Corporation (AGTC:NASDAQ), 122.84%
- Trillium Therapeutics Inc. (TRIL:NASDAQ), 93.96%
- Genetic Technologies Limited (GENE:NASDAQ), 45.09%
- Titan Pharmaceuticals, Inc. (TTNP:NASDAQ), 36.53%
- Novus Therapeutics, Inc. (NVUS:NASDAQ), 35.71%
- La Jolla Pharmaceutical Company (LJPC:NASDAQ), 34.96%
- The Peck Company Holdings, Inc. (PECK:NASDAQ), 34.71%
- Capricor Therapeutics, Inc. (CAPR:NASDAQ), 33.59%
- KemPharm, Inc. (KMPH:NASDAQ), 31.72%
- Proteon Therapeutics, Inc. (PRTO:NASDAQ), 30.5%